Insiders · Profile

Vavricka John

Chief Commercial Officer at Atea Pharmaceuticals. Filing since 1 Feb 2024. CIK 0001829630

Company

Date

Role

Action

Amount

Of holding

1 Feb 2024

Chief Commercial Officer

Sold at will

11,819

$45.42K

35.5%

1 decision on file.